Ar­genx files for a $75M IPO; PDU­FA date loom­ing, Bio­Marin wins CHMP nod for Brineu­ra

→ Bel­gium’s Ar­genx has joined the IPO queue in the US, look­ing to trig­ger a $75 mil­lion of­fer­ing by at­tract­ing in­vestors to its an­ti­body Fc …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.